Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Read Article
News
2024
2023
Archive
Search news articles
May 19, 2020
Pear Therapeutics Wins 2020 MedTech Breakthrough Award for Digital Health Innovation
May 19, 2020
Rallybio Completes $145 Million Series B Financing and Announces Plans to Advance Lead Product Candidate into the Clinic in 2H 2020
May 19, 2020
Cabaletta Bio Announces Presentation of Data Supporting MuSK-CAART Development for the Treatment of the MuSK form of Myasthenia Gravis at the AAN 2020 Science Highlights Virtual Platform
May 18, 2020
IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program
May 15, 2020
Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations
May 14, 2020
Arvinas Announces Updated Phase 1 Data Demonstrating Clinical Activity of PROTAC® Protein Degrader ARV-110 in Patients with Refractory Prostate Cancer
May 8, 2020
Entos and Precision NanoSystems Partner to Enable GMP Manufacturing of DNA COVID-19 Vaccine
May 6, 2020
Pear Therapeutics Launches Pear Assistance Program to Ensure Access to Prescription Digital Therapeutics, reSET® and reSET-O®, for People Living with Addiction
May 6, 2020
Cabaletta Bio Receives FDA Fast Track Designation for DSG3-CAART for the Treatment of Mucosal Pemphigus Vulgaris
May 6, 2020
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCS from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
« Previous Page
1
…
9
10
11
12
13
14
Next Page »